GECINA - REFERENCE DOCUMENT 2017

04

ANNUAL FINANCIAL STATEMENTS Notes to the annual financial statements at December 31, 2017

Change in share capital and shareholders’ equity

4.3.4.6

Net shareholders equity excluding earnings for the year and

Issue, merger and conversion premiums

Revalu- ation gain/loss Reserves

Distribution of dividends

Retained earnings

Share capital

Capital

subsidies Income Subsidies

In €’000

12/31/2015

474,455 1,905,293 445,535 765,689

3,590,971 284,497

1,347 3,876,815

Capital increase (employees) Account transfers Other changes 2015 Income appropriation 2016 Net income Capital increase Capital increase (employees) Account transfers Other changes 2016 Income appropriation 2017 Net income 12/31/2016

1,305 13,623

130

15,058

15,058

16,620

(16,620)

169

169

(29,286)

(29,286) (284,497)

(313,783) 469,119

313,783

469,119

475,760 1,918,916 428,915 753,153

3,576,743 469,119

1,516 4,047,378

88,395 1,244,465

1,332,860

1,332,860

1,071 11,935

13,006

13,006

10,619

(10,619)

(236)

(236)

146,955 146,955 (469,119)

(322,163)

322,163

333,385 333,385 12/31/2017 565,226 3,175,315 418,295 763,772 146,955 5,069,564 333,385 1,280 5,404,230 322,163

At year-end 2017, the capital was composed of 75,363,444 shares with a par value of €7.50 each. The company carried out a capital increase on August 11, 2017 via the issue of 9,062,091 shares at €110.50, for a total of €1,001 million, of which €68 million in capital and €933 million in issue premium. The fees for the capital

increase were allocated to the issue premium in the amount of €19 million. On October 17, 2017, 2,723,890 new shares were issued as part of the public offer for exchange of shares and Eurosic OSRA, representing a capital increase of €20 million and an issue premium of €331 million.

118 GECINA - REFERENCE DOCUMENT 2017

www.gecina.fr